FDA Approval Makes Rocket Pharma Gene Therapy the First for Ultra-Rare Immune Disorder

Rocket Pharmaceuticals received FDA approval for Kresladi, a gene therapy developed to treat leukocyte-adhesion deficiency type 1, an inherited immunodeficiency that can become fatal to infants and young children. Kresladi is the first gene therapy for this ultra-rare disease and the first commercial product for Rocket. The post FDA Approval Makes Rocket Pharma Gene Therapy…

Read More

How Are Health Systems Assessing ROI for AI Tools?

Michael Meucci, CEO of health data platform Arcadia, thinks health systems are changing their thinking about ROI when it comes to AI projects. As providers face tighter budgets, he said they’re broadening how they measure AI’s ROI, including benefits like reducing clinician burnout. The post How Are Health Systems Assessing ROI for AI Tools? appeared…

Read More

DOJ Cracks Down on Unfair Contracts with New Lawsuit Against NewYork-Presbyterian

The Department of Justice filed an antitrust lawsuit against NewYork-Presbyterian, alleging the hospital used “all-or-nothing” contracts that blocked lower-cost plans and limited competition. The case comes just five weeks after the Justice Department filed a similar lawsuit against OhioHealth. The post DOJ Cracks Down on Unfair Contracts with New Lawsuit Against NewYork-Presbyterian appeared first on…

Read More

How Real-World Data Is Reshaping the NSCLC Patient Journey

[Sponsored] A new eBook, sponsored by PurpleLab, examines how a significant number of patients with non-small cell lung cancer miss out on optimal care due to gaps in biomarker testing, socioeconomic barriers, incomplete patient journey data, and what can be done to change that. The post How Real-World Data Is Reshaping the NSCLC Patient Journey…

Read More